PUBLIC EVIDENCE LAB

Inspect Timory's source links, recurrence rules and explicit unknowns. Have an internal positioning decision? The private Sprint uses a separate evidence boundary.

See the private Research Sprint →

Name a market. We will look for recurring, source-linked evidence—not tell you what to build.

LAST COLLECTION 3h ago7914 SIGNALS8 FEEDS574 PAYMENT-EVIDENCE SIGNALS
#DossierEvidence levelRecurrenceRecency
1101 Opportunity dossier O-0713 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1102 Opportunity dossier O-0711 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1103 Opportunity dossier O-0707 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1104 Opportunity dossier O-0702 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1105 Opportunity dossier O-0693 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1106 Opportunity dossier O-0691 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1107 Opportunity dossier O-0688 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1108 Opportunity dossier O-0682 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1109 Opportunity dossier O-0675 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1110 Opportunity dossier O-0674 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1111 Opportunity dossier O-0673 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1112 Opportunity dossier O-0672 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1113 Opportunity dossier O-0671 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1114 Opportunity dossier O-0668 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1115 Opportunity dossier O-0664 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1116 Opportunity dossier O-0662 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1117 Opportunity dossier O-0661 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1118 Opportunity dossier O-0660 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1119 Opportunity dossier O-0659 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1120 Opportunity dossier O-0654 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02

Public dossiers offer free email unlock for the full evidence chain. Free Market Watch is self-serve: name a niche, preview matching dossiers and save change alerts over Timory's shared corpus.